CRH Medical (CRM) Stock Price, News & Analysis

Company Overview

CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.67 million shs
• Average Volume: 5.83 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CRM Stock Analysis - Frequently Asked Questions

How do I buy shares of CRH Medical?

Shares of CRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CRH Medical investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Pfizer (PFE) and PayPal (PYPL).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: N/A
• Industry: Software Publishers
• Sub-Industry: Computer Software
• Current Symbol: CVE:CRM
• CIK: N/A
• Web: investors.crhsystem.com
• Phone: +1-604-6331440
• Fax: N/A
• Employees: 73,500
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A